| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2013-06-12 17:33:21 UTC |
|---|
| Update Date | 2021-09-14 15:44:46 UTC |
|---|
| HMDB ID | HMDB0060546 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Norbuprenorphine |
|---|
| Description | Norbuprenorphine is the primary active metabolite of buprenorphine. Norbuprenorphine acts as a μ-opioid, δ-opioid, and nociceptin receptor full agonist, as well as a κ-opioid receptor partial agonist. Norbuprenorphine crosses the blood-brain-barrier similarly to buprenorphine and likely contributes to its effects. It was observed that Intravenous administration of norbuprenorphine at 1 to 3 mg/kg decreased respiratory rate, whereas buprenorphine had no effect up to 3 mg/kg in rats. (Wikipedia ) |
|---|
| Structure | CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1)=C(O)C=C4 InChI=1S/C25H35NO4/c1-21(2,3)22(4,28)16-13-23-8-9-25(16,29-5)20-24(23)10-11-26-17(23)12-14-6-7-15(27)19(30-20)18(14)24/h6-7,16-17,20,26-28H,8-13H2,1-5H3/t16-,17-,20-,22+,23-,24+,25-/m1/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| Des(cyclopropylmethyl)buprenorphine | HMDB | | N-Desalkylbuprenorphine | HMDB |
|
|---|
| Chemical Formula | C25H35NO4 |
|---|
| Average Molecular Weight | 413.5497 |
|---|
| Monoisotopic Molecular Weight | 413.256608613 |
|---|
| IUPAC Name | (1S,2R,6S,14R,15R,16R)-16-[(2S)-2-hydroxy-3,3-dimethylbutan-2-yl]-15-methoxy-13-oxa-3-azahexacyclo[13.2.2.1²,⁸.0¹,⁶.0⁶,¹⁴.0⁷,¹²]icosa-7,9,11-trien-11-ol |
|---|
| Traditional Name | (1S,2R,6S,14R,15R,16R)-16-[(2S)-2-hydroxy-3,3-dimethylbutan-2-yl]-15-methoxy-13-oxa-3-azahexacyclo[13.2.2.1²,⁸.0¹,⁶.0⁶,¹⁴.0⁷,¹²]icosa-7,9,11-trien-11-ol |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1)=C(O)C=C4 |
|---|
| InChI Identifier | InChI=1S/C25H35NO4/c1-21(2,3)22(4,28)16-13-23-8-9-25(16,29-5)20-24(23)10-11-26-17(23)12-14-6-7-15(27)19(30-20)18(14)24/h6-7,16-17,20,26-28H,8-13H2,1-5H3/t16-,17-,20-,22+,23-,24+,25-/m1/s1 |
|---|
| InChI Key | YOYLLRBMGQRFTN-IOMBULRVSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as phenanthrenes and derivatives. These are polycyclic compounds containing a phenanthrene moiety, which is a tricyclic aromatic compound with three non-linearly fused benzene. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Benzenoids |
|---|
| Class | Phenanthrenes and derivatives |
|---|
| Sub Class | Not Available |
|---|
| Direct Parent | Phenanthrenes and derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Phenanthrene
- Azaspirodecane
- Tetralin
- Coumaran
- Alkyl aryl ether
- 1-hydroxy-2-unsubstituted benzenoid
- Aralkylamine
- Piperidine
- Tertiary alcohol
- Dialkyl ether
- Secondary aliphatic amine
- Ether
- Secondary amine
- Oxacycle
- Azacycle
- Organoheterocyclic compound
- Organonitrogen compound
- Amine
- Organooxygen compound
- Organopnictogen compound
- Hydrocarbon derivative
- Organic oxygen compound
- Alcohol
- Organic nitrogen compound
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 5.99 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 11.3217 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 3.94 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 2187.5 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 155.3 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 190.4 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 147.0 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 81.6 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 590.9 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 439.2 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 227.1 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 915.3 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 438.2 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1231.8 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 314.5 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 296.2 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 242.4 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 194.6 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 8.1 seconds | 40023050 |
Predicted Kovats Retention IndicesDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Norbuprenorphine,1TMS,isomer #1 | CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O[Si](C)(C)C)C(C)(C)C)[C@H]1CC4=CC=C(O)C5=C4[C@@]3(CCN1)[C@H]2O5 | 3068.2 | Semi standard non polar | 33892256 | | Norbuprenorphine,1TMS,isomer #2 | CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=CC=C(O[Si](C)(C)C)C5=C4[C@@]3(CCN1)[C@H]2O5 | 3120.3 | Semi standard non polar | 33892256 | | Norbuprenorphine,1TMS,isomer #3 | CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=CC=C(O)C5=C4[C@@]3(CCN1[Si](C)(C)C)[C@H]2O5 | 3076.9 | Semi standard non polar | 33892256 | | Norbuprenorphine,2TMS,isomer #1 | CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O[Si](C)(C)C)C(C)(C)C)[C@H]1CC4=CC=C(O[Si](C)(C)C)C5=C4[C@@]3(CCN1)[C@H]2O5 | 3094.8 | Semi standard non polar | 33892256 | | Norbuprenorphine,2TMS,isomer #2 | CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O[Si](C)(C)C)C(C)(C)C)[C@H]1CC4=CC=C(O)C5=C4[C@@]3(CCN1[Si](C)(C)C)[C@H]2O5 | 3056.0 | Semi standard non polar | 33892256 | | Norbuprenorphine,2TMS,isomer #3 | CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=CC=C(O[Si](C)(C)C)C5=C4[C@@]3(CCN1[Si](C)(C)C)[C@H]2O5 | 3093.2 | Semi standard non polar | 33892256 | | Norbuprenorphine,3TMS,isomer #1 | CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O[Si](C)(C)C)C(C)(C)C)[C@H]1CC4=CC=C(O[Si](C)(C)C)C5=C4[C@@]3(CCN1[Si](C)(C)C)[C@H]2O5 | 3131.5 | Semi standard non polar | 33892256 | | Norbuprenorphine,3TMS,isomer #1 | CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O[Si](C)(C)C)C(C)(C)C)[C@H]1CC4=CC=C(O[Si](C)(C)C)C5=C4[C@@]3(CCN1[Si](C)(C)C)[C@H]2O5 | 3386.3 | Standard non polar | 33892256 | | Norbuprenorphine,3TMS,isomer #1 | CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O[Si](C)(C)C)C(C)(C)C)[C@H]1CC4=CC=C(O[Si](C)(C)C)C5=C4[C@@]3(CCN1[Si](C)(C)C)[C@H]2O5 | 3281.2 | Standard polar | 33892256 | | Norbuprenorphine,1TBDMS,isomer #1 | CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O[Si](C)(C)C(C)(C)C)C(C)(C)C)[C@H]1CC4=CC=C(O)C5=C4[C@@]3(CCN1)[C@H]2O5 | 3321.0 | Semi standard non polar | 33892256 | | Norbuprenorphine,1TBDMS,isomer #2 | CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=CC=C(O[Si](C)(C)C(C)(C)C)C5=C4[C@@]3(CCN1)[C@H]2O5 | 3342.4 | Semi standard non polar | 33892256 | | Norbuprenorphine,1TBDMS,isomer #3 | CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=CC=C(O)C5=C4[C@@]3(CCN1[Si](C)(C)C(C)(C)C)[C@H]2O5 | 3285.2 | Semi standard non polar | 33892256 | | Norbuprenorphine,2TBDMS,isomer #1 | CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O[Si](C)(C)C(C)(C)C)C(C)(C)C)[C@H]1CC4=CC=C(O[Si](C)(C)C(C)(C)C)C5=C4[C@@]3(CCN1)[C@H]2O5 | 3527.7 | Semi standard non polar | 33892256 | | Norbuprenorphine,2TBDMS,isomer #2 | CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O[Si](C)(C)C(C)(C)C)C(C)(C)C)[C@H]1CC4=CC=C(O)C5=C4[C@@]3(CCN1[Si](C)(C)C(C)(C)C)[C@H]2O5 | 3500.8 | Semi standard non polar | 33892256 | | Norbuprenorphine,2TBDMS,isomer #3 | CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=CC=C(O[Si](C)(C)C(C)(C)C)C5=C4[C@@]3(CCN1[Si](C)(C)C(C)(C)C)[C@H]2O5 | 3521.0 | Semi standard non polar | 33892256 | | Norbuprenorphine,3TBDMS,isomer #1 | CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O[Si](C)(C)C(C)(C)C)C(C)(C)C)[C@H]1CC4=CC=C(O[Si](C)(C)C(C)(C)C)C5=C4[C@@]3(CCN1[Si](C)(C)C(C)(C)C)[C@H]2O5 | 3764.3 | Semi standard non polar | 33892256 | | Norbuprenorphine,3TBDMS,isomer #1 | CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O[Si](C)(C)C(C)(C)C)C(C)(C)C)[C@H]1CC4=CC=C(O[Si](C)(C)C(C)(C)C)C5=C4[C@@]3(CCN1[Si](C)(C)C(C)(C)C)[C@H]2O5 | 4023.3 | Standard non polar | 33892256 | | Norbuprenorphine,3TBDMS,isomer #1 | CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O[Si](C)(C)C(C)(C)C)C(C)(C)C)[C@H]1CC4=CC=C(O[Si](C)(C)C(C)(C)C)C5=C4[C@@]3(CCN1[Si](C)(C)C(C)(C)C)[C@H]2O5 | 3540.5 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Norbuprenorphine GC-MS (Non-derivatized) - 70eV, Positive | splash10-0a4i-9135000000-45e0d329ab9294ed4317 | 2017-09-20 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Norbuprenorphine GC-MS (2 TMS) - 70eV, Positive | splash10-05g3-9001010000-5c6c16b735846e565925 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Norbuprenorphine GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Norbuprenorphine GC-MS (TMS_2_2) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Norbuprenorphine GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Norbuprenorphine GC-MS (TBDMS_2_1) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Norbuprenorphine GC-MS (TBDMS_2_2) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Norbuprenorphine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Norbuprenorphine GC-MS ("Norbuprenorphine,1TMS,#1" TMS) - 70eV, Positive | Not Available | 2021-10-14 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - Norbuprenorphine LC-ESI-QTOF , positive-QTOF | splash10-03di-0000900000-d0e136497c0156c9680f | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Norbuprenorphine LC-ESI-QTOF , positive-QTOF | splash10-03di-0000900000-b04b0200f02b897bb6ef | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Norbuprenorphine LC-ESI-QTOF , positive-QTOF | splash10-03di-0000900000-18c86464a0d8a8e11bf8 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Norbuprenorphine LC-ESI-QTOF , positive-QTOF | splash10-03di-0143900000-52c84cfc3c7de4f83891 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Norbuprenorphine LC-ESI-QTOF , positive-QTOF | splash10-03dr-0490100000-61fc9d6ff83269e9fe09 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Norbuprenorphine 50V, Positive-QTOF | splash10-03ki-0691100000-b93b4447efa37aa300b0 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Norbuprenorphine 40V, Positive-QTOF | splash10-03di-0263900000-362c7ffa1fc4db260e07 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Norbuprenorphine 50V, Positive-QTOF | splash10-03ki-0691100000-cc22b459c3503e03c2de | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Norbuprenorphine 30V, Positive-QTOF | splash10-03di-0000900000-a17b5bb24d801a8703c5 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Norbuprenorphine 20V, Positive-QTOF | splash10-03di-0000900000-7f319d742b7c88e6d294 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Norbuprenorphine 50V, Positive-QTOF | splash10-03dr-0490100000-61fc9d6ff83269e9fe09 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Norbuprenorphine 10V, Positive-QTOF | splash10-03di-0000900000-e8bb505ed3edc3b3f233 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Norbuprenorphine 20V, Positive-QTOF | splash10-03di-0000900000-b04b0200f02b897bb6ef | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Norbuprenorphine 10V, Positive-QTOF | splash10-03di-0000900000-d0e136497c0156c9680f | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Norbuprenorphine 30V, Positive-QTOF | splash10-03di-0000900000-18c86464a0d8a8e11bf8 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Norbuprenorphine 40V, Positive-QTOF | splash10-03di-0143900000-52c84cfc3c7de4f83891 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Norbuprenorphine 10V, Positive-QTOF | splash10-01ot-0009500000-f9107c3bc2684b887bb9 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Norbuprenorphine 20V, Positive-QTOF | splash10-01ot-1009200000-5c2addf9f89749701055 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Norbuprenorphine 40V, Positive-QTOF | splash10-001i-4109000000-29b63bd2b3e8e8942b95 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Norbuprenorphine 10V, Negative-QTOF | splash10-03di-0003900000-96dbf2e34e2566985c4e | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Norbuprenorphine 20V, Negative-QTOF | splash10-03di-2129500000-c9958eaf16725890f647 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Norbuprenorphine 40V, Negative-QTOF | splash10-0002-1194000000-e835394a1e996708aa1c | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Norbuprenorphine 10V, Positive-QTOF | splash10-03di-0000900000-22add0760b63a0f18d04 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Norbuprenorphine 20V, Positive-QTOF | splash10-03di-0001900000-bf64a5b4def2ecf8bf30 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Norbuprenorphine 40V, Positive-QTOF | splash10-03di-0003900000-17c40c03c2942ffaf0ba | 2021-10-12 | Wishart Lab | View Spectrum |
|
|---|